Abstract
Objective
To compare the efficacy of insulin infusion of 0.05 Unit/kg/hour vs 0.1 Unit/kg/hour in the management of pediatric diabetic ketoacidosis (DKA).
Design
Randomized, double-blind controlled clinical trial.
Setting
Pediatric critical care division of a tertiary care hospital from October, 2014 to July, 2018.
Participants
Children aged 12 years or younger with a diagnosis of DKA. Children with septic shock and those who had received insulin before enrollment were excluded.
Intervention
Low-dose (0.05 Unit/kg/hour) vs. Standard-dose (0.1 Unit/kg/hour) insulin infusion.
Outcome measures
The primary endpoint was time for resolution of DKA (pH ≥7.3, bicarbonate ≥15 mEq/L, beta-hydroxybutyrate <1 mmol/L). Secondary outcomes were the rate of fall in blood glucose until 250 mg/dL or less and the rate of complications (hypokalemia, hypoglycemia, and cerebral edema).
Results
Sixty patients were analyzed on an intention-to-treat basis (Low-dose group: n=30; Standard-dose group: n=30). Mean (SD) time taken for the resolution of ketoacidosis was similar in both groups [22 (12) vs 23 (18.5) hours; P=0.92]. The adjusted hazard ratio (95% CI) of the resolution of ketoacidosis was lower in the low-dose group [0.40 (0.19 to 0.85); P=0.017]. Mean (SD) rate of blood glucose decrease until 250 mg/dL or less reached [56 (41) vs 64 (65) mg/dL/hour; P=0.41] and time to achieve the target [4.2 (3.1) vs 4.8 (3.3) hours; P=0.44] were similar in both groups. Hypokalemia [30% vs 43.3%; P=0.28] and hypoglycemia [3.3% vs 13.3%; P=0.35] were lower in low-dose group. No child had cerebral edema, and no mortality occurred.
Conclusions
Time for resolution of ketoacidosis was similar in the low-dose and standard-dose insulin with a lower rate of therapy-related complications in the low-dose group. Hence, low-dose insulin infusion can be a safer approach in the management of pediatric DKA.
Similar content being viewed by others
References
Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19:155–77.
Kanwal SK, Bando A, Kumar V. Clinical profile of diabetic ketoacidosis in Indian children. Indian J Pediatr. 2012;79:901–4.
Tiwari LK, Jayashree M, Singhi S. Risk factors for cerebral edema in diabetic ketoacidosis in a developing country: Role of fluid refractory shock. Pediatr Crit Care Med. 2012;13:e91–6.
Jayashree M, Singhi S. Diabetic ketoacidosis: Predictors of outcome in a pediatric intensive care unit of a developing country. Pediatr Crit Care Med. 2004;5:427–33.
Poovazhagi V. Risk factors for mortality in children with diabetic keto acidosis from developing countries. World J Diabetes. 2014;5:932–8.
Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes. 1988;37: 1470–7.
Alberti KG, Hockaday TD, Turner RC. Small doses of intramuscular insulin in the treatment of diabetic “coma”. Lancet. 1973;2:515–22.
Kitabchi AE, Ayyagari V, Guerra SM. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann Intern Med. 1976;84:633–8.
Burghen GA, Etteldorf JN, Fisher JN, Kitabchi AQ. Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care. 1980;3:15–20.
Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004;89:188–94.
Noyes KJ, Crofton P, Bath LE, et al. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2007;8:150–6.
Puttha R, Cooke D, Subbarayan A, et al. Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study. Pediatr Diabetes. 2010;11:12–7.
Al Hanshi S, Shann F. Insulin infused at 0.05 versus 0.1 units/kg/hr in children admitted to intensive care with diabetic ketoacidosis. Pediatr Crit Care Med. 2011;12:137–40.
Nallasamy K, Jayashree M, Singhi S, Bansal A. Low-dose vs standard-dose insulin in pediatric diabetic ketoacidosis: A randomized clinical trial. JAMA Pediatr. 2014;168:999–1005.
de Onis M, Blossner M. The World Health Organization Global Database on Child Growth and Malnutrition: methodology and applications. Int J Epidemiol. 2003;32:518–26.
Muir AB, Quisling RG, Yang MC, Rosenbloom AL. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care. 2004;27:1541–6.
Kump PM, Rameshkumar R, Soundravally R, Satheesh P. Capillary versus Serum b-hydroxybutyrate in Pediatric Diabetic Ketoacidosis. Indian Pediatr. 2019;56:126–9.
Soler NG, FitzGerald MG, Wright AD, Malins JM. Comparative study of different insulin regimens in management of diabetic ketoacidosis. Lancet. 1975;2: 1221–4.
Kapellen T, Vogel C, Telleis D, Siekmeyer M, Kiess W. Treatment of diabetic ketoacidosis (DKA) with 2 different regimens regarding fluid substitution and insulin dosage (0.025 vs. 0.1 units/kg/h). Exp Clin Endocrinol Diabetes. 2012;120:273–6.
Bradley P, Tobias JD. Serum glucose changes during insulin therapy in pediatric patients with diabetic ketoacidosis. Am J Ther. 2007;14:265–8.
Edge JA, Jakes RW, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49:2002–9.
Moulik NR, Jayashree M, Singhi S, Bhalla AK, Attri S. Nutritional status and complications in children with diabetic ketoacidosis. Pediatr Crit Care Med. 2012;13:e227–33.
Acknowledgments
Dr. Poovazhagi V (Head of Department. Pediatric Intensive Care Unit, Professor of Pediatrics, Institute of Child Health, Chennai, India) for critical review of the manuscript; Mrs. S. Raja Deepa B.Com, MCA (JIPMER Campus, Puducherry, India) for data handling, review and editing of the manuscript; Mr. Rakesh Mohindra (Punjab University, Chandigarh, India) and Mrs. Thenmozhi M M.Sc, Ph.D.,(Senior Demonstrator, CMC, Vellore, India) helping with statistical analysis and Mrs. Harpreet Kaur (Punjab University, Chandigarh, India), and Mrs. Neelima Chadha (Tulsi Das Library, PGIMER, Chandigarh, India) helping with the medical literature search. The preliminary data were presented at the 9th World Congress of Pediatric Intensive and Critical Care (PICC 2018, Singapore). Ethics approval: Institute Ethics Committee of JIPMER, Puducherry; No. JIP/IEC/2014/4/308, dated 27 June, 2014. Contributors: RR: conceptualized the study, reviewed the literature, and critically reviewed the manuscript; JA, PS, PJ, SA, SS: data collection, reviewed the literature and contribution of manuscript writing; NP, SM: protocol development, review of literature and manuscript writing. All authors involved in the management of the patients and approved the final version of the manuscript. RR, SM: study supervision.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding
Supported in part by the institutional and departmental fund
Competing interest
None stated.
Rights and permissions
About this article
Cite this article
Rameshkumar, R., Satheesh, P., Jain, P. et al. Low-Dose (0.05 Unit/kg/hour) vs Standard-Dose (0.1 Unit/kg/hour) Insulin in the Management of Pediatric Diabetic Ketoacidosis: A Randomized Double-Blind Controlled Trial. Indian Pediatr 58, 617–623 (2021). https://doi.org/10.1007/s13312-021-2255-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-021-2255-x